Drug Trial Radar · NCT05118750
ALTO-300 in Depression
Last checked: Nov 20, 2026Latest source record: Apr 30, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
91
Actual
Start
Dec 13, 2021
Primary completion
May 5, 2023
Study completion May 9, 2023
Sponsor
- Lead sponsor
- Alto NeuroscienceIndustry
- Sponsor type
- Industry
- First posted
- Nov 12, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to collect biologically-based data for defining predictors and correlates of the effects of ALTO-300.
Conditions
- Major Depressive Disorder
Interventions
ALTO-300 oral (PO) tabletDrug
One tablet daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- To understand the relationship between baseline biology and clinical outcome to ALTO-300 using the Montgomery-Åsberg Depression Rating Scale (MADRS)Time frame: Measured 6 times over 8 weeks
- To understand the relationship between baseline biology and clinical outcome to ALTO-300 using the Clinical Global Impression scale - Severity (CGI-S)Time frame: Measured 6 times over 8 weeks
- To evaluate the safety of ALTO-300Time frame: From the signing of the ICF until the follow-up visit (up to 12 weeks)
- To evaluate the safety of ALTO-300Time frame: From the signing of the ICF until the end-of-treatment visit (up to 11 weeks)
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Site 153
Culver City, California
Site 103
Sacramento, California
Site 158
Santee, California
Site 159
Clermont, Florida
Site 161
Okeechobee, Florida
Site 137
Noblesville, Indiana
Site 166
Saint Charles, Missouri
Site 132
New York, New York
Site 102
Dallas, Texas
Site 165
DeSoto, Texas
Site 147
Fort Worth, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.